Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD
Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD
Not yet recruiting · NCT06839339 · Registry updated 2025-02-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD | Wet Age-related Macular Degeneration (wAMD) | Not yet recruiting | Phase 2 | 2025-02-21 | NCT06839339 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Anlong Biopharmaceutical Co., Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Sciences & Peking Union Hospital | Beijing | China | 2 |